Sernova Corp. (TSE:SVA – Get Free Report) shares were down 4.5% during trading on Friday . The company traded as low as C$0.21 and last traded at C$0.21. Approximately 56,087 shares were traded during trading, a decline of 64% from the average daily volume of 157,444 shares. The stock had previously closed at C$0.22.
Sernova Price Performance
The business has a 50-day simple moving average of C$0.23 and a 200 day simple moving average of C$0.25. The firm has a market cap of C$68.32 million, a P/E ratio of -1.62 and a beta of 1.35. The company has a debt-to-equity ratio of 16.55, a quick ratio of 18.11 and a current ratio of 0.32.
About Sernova
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Featured Articles
- Five stocks we like better than Sernova
- What is the NASDAQ Stock Exchange?
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Investing In Automotive Stocks
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Differences Between Momentum Investing and Long Term Investing
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
